SHARE
Recombinant Factor C Assay Market

Recombinant Factor C Assay - Global Market Outlook (2019-2027)

4.0 (71 reviews)
Published: June 2020 ID: SMRC19301
4.0 (71 reviews)
Published: June 2020 ID: SMRC19301

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Recombinant Factor C Assay Market is accounted for $14.29 million in 2019 and is expected to reach $30.40 million by 2027 growing at a CAGR of 9.9% during the forecast period. The rise in need of alternative endotoxin detection tests and cost advantages by helping in reducing the operator risks is propelling the market growth. However, the lack of long-term studies that validate rFC for combination testing of unknown samples is hampering the market growth.

Recombinant factor C (rFC) assay is an alternative to LAL tests utilized for endotoxin testing of the products for pyrogens. Recombinant factor C (rFC) assay is a synthetic correspondent of Factor C and is the first part of the horseshoe crab clotting cascade, which is activated in response to endotoxins.

Based on the brand, the PyroGene segment is going to have a lucrative growth during the forecast period as it is being the first marketed rFC assay product used as an alternative to LAL tests and also it is one of the main products tested as an alternative to LAL tests to conserve the Limulus species. By geography, Asia Pacific is going to have a lucrative growth during the forecast period due to incorporation of rFC as a recognized endotoxin detection test by pharmacopoeias, and focus on conservation of the Limulus species.

Some of the key players profiled in the Recombinant Factor C Assay Market include Hyglos GmbH – a bioMérieux Company and Lonza Group.

End Users Covered:
• Contract Research Organizations (CROs)
• Biotechnology Companies
• Medical Device Companies 
• Pharmaceutical Companies

Brands Covered:
• EndoNext
• PyroGene  

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary       
         
2 Preface 
       
 2.1 Abstract       
 2.2 Stake Holders      
 2.3 Research Scope      
 2.4 Research Methodology     
  2.4.1 Data Mining     
  2.4.2 Data Analysis     
  2.4.3 Data Validation     
  2.4.4 Research Approach     
 2.5 Research Sources      
  2.5.1 Primary Research Sources    
  2.5.2 Secondary Research Sources    
  2.5.3 Assumptions     
         
3 Market Trend Analysis      
 3.1 Introduction      
 3.2 Drivers       
 3.3 Restraints      
 3.4 Opportunities      
 3.5 Threats       
 3.6 End User Analysis      
 3.7 Emerging Markets      
 3.8 Impact of Covid-19      
         
4 Porters Five Force Analysis      
 4.1 Bargaining power of suppliers     
 4.2 Bargaining power of buyers     
 4.3 Threat of substitutes     
 4.4 Threat of new entrants     
 4.5 Competitive rivalry      
         
5 Global Recombinant Factor C Assay Market, By End User   

 5.1 Introduction      
 5.2 Contract Research Organizations (CROs)    
 5.3 Biotechnology Companies     
 5.4 Medical Device Companies      
 5.5 Pharmaceutical Companies     
         
6 Global Recombinant Factor C Assay Market, By Brand   
 6.1 Introduction      
 6.2 EndoNext      
  6.2.1 Endozyme II GO     
  6.2.2 EndoLisa      
  6.2.3 Endozyme II     
 6.3 PyroGene      
  6.3.1 PyroGene rFC (192 tests)    
  6.3.2 PyroGene Bulk rFC (2,880 tests)   
         
7 Global Recombinant Factor C Assay Market, By Geography   
 7.1 Introduction      
 7.2 North America      
  7.2.1 US      
  7.2.2 Canada      
  7.2.3 Mexico      
 7.3 Europe       
  7.3.1 Germany      
  7.3.2 UK      
  7.3.3 Italy      
  7.3.4 France      
  7.3.5 Spain      
  7.3.6 Rest of Europe     
 7.4 Asia Pacific      
  7.4.1 Japan      
  7.4.2 China      
  7.4.3 India      
  7.4.4 Australia      
  7.4.5 New Zealand     
  7.4.6 South Korea     
  7.4.7 Rest of Asia Pacific     
 7.5 South America      
  7.5.1 Argentina     
  7.5.2 Brazil      
  7.5.3 Chile      
  7.5.4 Rest of South America    
 7.6 Middle East & Africa     
  7.6.1 Saudi Arabia     
  7.6.2 UAE      
  7.6.3 Qatar      
  7.6.4 South Africa     
  7.6.5 Rest of Middle East & Africa    
         
8 Key Developments      
 
 8.1 Agreements, Partnerships, Collaborations and Joint Ventures  
 8.2 Acquisitions & Mergers     
 8.3 New Product Launch      
 8.4 Expansions      
 8.5 Other Key Strategies     
         
9 Company Profiling       
 9.1 Hyglos GmbH – a bioMérieux Company    
 9.2 Lonza Group     


List of Tables        
1 Global  Recombinant Factor C Assay Market Outlook, By Region (2018-2027) ($MN) 
2 Global  Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
3 Global  Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
4 Global  Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
5 Global  Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
6 Global  Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
7 Global  Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN) 
8 Global  Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
9 Global  Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
10 Global  Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
11 Global  Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
12 Global  Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
13 Global  Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
14 Global  Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)
15 North America  Recombinant Factor C Assay Market Outlook, By Country (2018-2027) ($MN)
16 North America  Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
17 North America  Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
18 North America  Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
19 North America  Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
20 North America  Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
21 North America  Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
22 North America  Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
23 North America  Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
24 North America  Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
25 North America  Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
26 North America  Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
27 North America  Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
28 North America  Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)
29 Europe  Recombinant Factor C Assay Market Outlook, By Country (2018-2027) ($MN)
30 Europe  Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
31 Europe  Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
32 Europe  Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
33 Europe  Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
34 Europe  Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
35 Europe  Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN) 
36 Europe  Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
37 Europe  Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
38 Europe  Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
39 Europe  Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
40 Europe  Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
41 Europe  Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
42 Europe  Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)
43 Asia Pacific  Recombinant Factor C Assay Market Outlook, By Country (2018-2027) ($MN)
44 Asia Pacific  Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
45 Asia Pacific  Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
46 Asia Pacific  Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
47 Asia Pacific  Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
48 Asia Pacific  Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
49 Asia Pacific  Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
50 Asia Pacific  Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
51 Asia Pacific  Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
52 Asia Pacific  Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
53 Asia Pacific  Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
54 Asia Pacific  Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
55 Asia Pacific  Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
56 Asia Pacific  Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)
57 South America  Recombinant Factor C Assay Market Outlook, By Country (2018-2027) ($MN)
58 South America  Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
59 South America  Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
60 South America  Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
61 South America  Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
62 South America  Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
63 South America  Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
64 South America  Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
65 South America  Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
66 South America  Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
67 South America  Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
68 South America  Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
69 South America  Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
70 South America  Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)
71 Middle East & Africa  Recombinant Factor C Assay Market Outlook, By Country (2018-2027) ($MN)
72 Middle East & Africa  Recombinant Factor C Assay Market Outlook, By End User (2018-2027) ($MN)
73 Middle East & Africa  Recombinant Factor C Assay Market Outlook, By Contract Research Organizations (CROs) (2018-2027) ($MN)
74 Middle East & Africa  Recombinant Factor C Assay Market Outlook, By Biotechnology Companies (2018-2027) ($MN)
75 Middle East & Africa  Recombinant Factor C Assay Market Outlook, By Medical Device Companies (2018-2027) ($MN)
76 Middle East & Africa  Recombinant Factor C Assay Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
77 Middle East & Africa  Recombinant Factor C Assay Market Outlook, By Brand (2018-2027) ($MN)
78 Middle East & Africa  Recombinant Factor C Assay Market Outlook, By EndoNext (2018-2027) ($MN)
79 Middle East & Africa  Recombinant Factor C Assay Market Outlook, By Endozyme II GO (2018-2027) ($MN)
80 Middle East & Africa  Recombinant Factor C Assay Market Outlook, By EndoLisa (2018-2027) ($MN)
81 Middle East & Africa  Recombinant Factor C Assay Market Outlook, By Endozyme II (2018-2027) ($MN)
82 Middle East & Africa  Recombinant Factor C Assay Market Outlook, By PyroGene (2018-2027) ($MN)
83 Middle East & Africa  Recombinant Factor C Assay Market Outlook, By PyroGene rFC (192 tests) (2018-2027) ($MN)
84 Middle East & Africa  Recombinant Factor C Assay Market Outlook, By PyroGene Bulk rFC (2,880 tests) (2018-2027) ($MN)

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials